SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-07-023519
Filing Date
2007-02-08
Accepted
2007-02-08 09:23:43
Documents
1
Group Members
ATLAS GLOBAL INVESTMENTS II, LTD.ATLAS GLOBAL INVESTMENTS, LTD.ATLAS GLOBAL, LLCATLAS MASTER FUND, LTD.DMITRY BALYASNY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 dsc13ga.htm SC 13G/A 178874
  Complete submission text file 0001193125-07-023519.txt   180922
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Subject) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-57843 | Film No.: 07590331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602
Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A